Xu L L, Srikantan V, Sesterhenn I A, Augustus M, Dean R, Moul J W, Carter K C, Srivastava S
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20852, USA.
J Urol. 2000 Mar;163(3):972-9.
NKX3.1, a member of the family of homeobox genes, exhibits prostate tissue specific expression and appears to play a role in mouse prostate development. Rapid induction of NKX3.1 gene expression in response to androgens has also been described. On the basis of the established role of androgens in prostatic growth and differentiation and studies showing an association of aberrant homeobox gene expression with the neoplastic process, we hypothesize that alterations of NKX3.1 gene expression play a role in prostate tumorigenesis.
NKX3.1 expression was analyzed in matched, microdissected normal and tumor tissues from 52 primary prostate cancer specimens from radical prostatectomy by semiquantitative RT-PCR and in situ hybridization and correlated with the clinicopathologic features. NKX3.1 expression was quantified as differential expression between matched tumor and normal tissues and was grouped as overexpression in tumor tissue, reduced expression in tumor tissue and no change between tumor and normal tissues. Androgen regulation of NKX3.1 expression was also studied in LNCaP cells. Androgen receptor (AR) expression in prostate tumor and normal tissue was correlated with NKX3.1 expression.
Comparison of NKX3.1 expression between normal and tumor tissues revealed overexpression in 31% tumor specimens (16 of 52), decreased expression in 21% tumor specimens (11 of 52) and no change in 48% specimens (25 of 52). When these expression patterns were stratified by organ confined and non-organ-confined tumor, a higher percentage of patients exhibited NKX3.1 overexpression in non-organ confined tumor (40%) versus organ confined tumor (22%). Elevated NKX3.1 expression significantly correlated with tumor volume and serum prostate specific antigen (PSA) level in the NKX3.1 overexpression group (p<0.05). Metastatic prostate cancer cell lines did not exhibit mutations in the protein coding sequence of NKX3.1. Additionally, the NKX3.1 expression correlated with AR expression (p<0.01) in vivo in human prostate tissues. Comparison of PSA and NKX3.1 expression in response to androgen revealed a rapid androgen mediated induction of NKX3.1 expression in LNCaP cells. In situ hybridization analysis of representative specimens confirmed RT-PCR observations.
These results suggest an association of NKX3.1 with a more aggressive phenotype of carcinoma of the prostate. Correlation of AR expression with NKX3.1 in human prostate tissues underscores the androgen regulation of NKX3.1 in the physiologic context of human prostate tissues.
NKX3.1是同源框基因家族的一员,在前列腺组织中特异性表达,似乎在小鼠前列腺发育中发挥作用。也有研究描述了其对雄激素的快速诱导反应。基于雄激素在前列腺生长和分化中的既定作用,以及研究表明异常的同源框基因表达与肿瘤形成过程相关,我们推测NKX3.1基因表达的改变在前列腺肿瘤发生中起作用。
通过半定量逆转录聚合酶链反应(RT-PCR)和原位杂交分析了52例前列腺癌根治术标本中经显微切割的配对正常组织和肿瘤组织中的NKX3.1表达,并与临床病理特征相关联。NKX3.1表达定量为配对肿瘤组织和正常组织之间的差异表达,并分为肿瘤组织中过表达、肿瘤组织中表达降低以及肿瘤组织和正常组织之间无变化。还在LNCaP细胞中研究了雄激素对NKX3.1表达的调节。前列腺肿瘤组织和正常组织中的雄激素受体(AR)表达与NKX3.1表达相关。
正常组织和肿瘤组织中NKX3.1表达的比较显示,31%的肿瘤标本(52例中的16例)过表达,21%的肿瘤标本(52例中的11例)表达降低,48%的标本(52例中的25例)无变化。当按器官局限性和非器官局限性肿瘤对这些表达模式进行分层时,非器官局限性肿瘤(40%)中NKX3.1过表达的患者百分比高于器官局限性肿瘤(22%)。在NKX3.1过表达组中,NKX3.1表达升高与肿瘤体积和血清前列腺特异性抗原(PSA)水平显著相关(p<0.05)。转移性前列腺癌细胞系在NKX3.1的蛋白质编码序列中未表现出突变。此外,在人前列腺组织中,NKX3.1表达与AR表达相关(p<0.01)。对雄激素反应时PSA和NKX3.1表达的比较显示,LNCaP细胞中雄激素介导了NKX3.1表达的快速诱导。代表性标本的原位杂交分析证实了RT-PCR的观察结果。
这些结果表明NKX3.1与前列腺癌更具侵袭性的表型相关。人前列腺组织中AR表达与NKX3.1的相关性强调了在人前列腺组织的生理背景下雄激素对NKX3.1的调节作用。